Stocks · Health care · Pharmaceutical Preparations

Arcutis Biotherapeutics, Inc.

ARQT Clue Score48
United States Fiscal year ends December CIK 0001787306 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Todd Watanabe
1 Dec 2023
See Remarks
Exercised, kept
59,525
$1.68
$100.04K
Scott L Burrows
16 Sep 2022
Chief Financial Officer
Exercised, kept
5,000
$1.68
$8.40K
Showing 250 of 407 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 397
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 126
Sales straight out of an exercise 112
Sales at will 110
Transactions with no price 0
Shares from compensation/vesting 37,290,752
Sales filed before the plan box existed 97
History held since 3 Feb 2020